Ledger.Open graph →
SEC Form D · filed December 20, 2021

Lexaria Bioscience Corp

Offering
$1.2M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Gregory Downey · Kelowna, British Columbia, CanadaExecTed Mckechnie · Kelowna, British Columbia, CanadaDirectorSebastian M. Wahl · Vancouver, British Columbia, CanadaExecNicholas Baxter · Kelowna, British Columbia, CanadaDirectorAlbert E. Reese · Kelowna, British Columbia, CanadaDirectorChristopher Bunka · Kelowna, British Columbia, CanadaExec · DirectorJohn Docherty · Kelowna, British Columbia, CanadaExec · DirectorBjorn C. Wettergren · Zurich, V8ExecTed Mckechnie · Kelowna, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗